ESYNNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

HWH International Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$1.75−0.19 (-9.79%)

Close on Oct 19, 2026

Market cap: $13.19M
P/E (TTM): –
Dividend yield: –

HWH International Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2022 2022-11-30
Revenue	0.87	1.25	–
Cost of Revenue	0.41	0.65	–
Gross Profit	0.46	0.60	–
General & Administrative	3.53	2.81	0.59
Advertising Expenses	0.12	0.02	–
Operating Expenses	3.65	3.19	0.69
Interest Expense	0.05	0.07	–
Interest & Investment Income	–	–	0.99
Income from Equity Investments	–	-0.02	–
Other Non-Operating Income	0.58	-0.18	0.99
Asset Impairment Charges	0.12	0.32	–
Gain (Loss) on Sale of Assets	–	-0.01	–
Pretax Income	-2.61	-2.77	0.30
Income Tax Expense	0.05	–	0.19
Net Income incl. Noncontrolling Interests	-2.66	-2.77	–
Minority Interest in Earnings	-0.03	-0.02	–
Net Income	-2.63	-2.75	0.11
EPS (Basic)(per share)	-0.40	-0.76	–
EPS (Diluted)(per share)	-0.40	-0.76	–
Shares Outstanding (Basic, Weighted)(shares)	6.56	3.61	–
Shares Outstanding (Diluted, Weighted)(shares)	6.56	3.61	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 59.2%
Operating margin: –
Net margin: -680.0%
Return on equity, FY2025: -97.7%

Financial strength

Current ratio: 1.82
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 92.1%

Valuation

P/E ratio: –
Price to sales: 33.85
Price to book: 4.82
Dividend yield: –